Long-Term Outcomes of Stereotactic Body Radiation Therapy with or without PD-1 Inhibitors in Metastatic Nasopharyngeal Carcinoma

被引:0
|
作者
Yang, J. [1 ]
He, J. [1 ]
Han, J. [1 ]
Zeng, N. [1 ]
Liao, W. [2 ]
机构
[1] Sichuan Univ, Canc Ctr, West China Hosp, Dept Neck Oncol, Chengdu, Sichuan, Peoples R China
[2] Univ Elect Sci & Technol China, Canc Hosp, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3284
引用
收藏
页码:E587 / E587
页数:1
相关论文
共 50 条
  • [1] Long-term outcomes of metastasis-directed stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma
    Yang, Jiangping
    Liao, Wenjun
    Su, Shitong
    Zeng, Ni
    Zhang, Shichuan
    He, Jinlan
    Chen, Nianyong
    [J]. CANCER MEDICINE, 2024, 13 (01):
  • [2] Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma
    Lin, Jing
    Guo, Qiaojuan
    Guo, Zengqing
    Lu, Tianzhu
    Chen, Gang
    Lin, Shaojun
    Chen, Mei
    Chen, Chuanben
    Lu, Jianping
    Zong, Jingfeng
    Tang, Lina
    Chen, Yu
    Pan, Jianji
    [J]. RADIATION ONCOLOGY, 2022, 17 (01)
  • [3] Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma
    Jing Lin
    Qiaojuan Guo
    Zengqing Guo
    Tianzhu Lu
    Gang Chen
    Shaojun Lin
    Mei Chen
    Chuanben Chen
    Jianping Lu
    Jingfeng Zong
    Lina Tang
    Yu Chen
    Jianji Pan
    [J]. Radiation Oncology, 17
  • [4] Stereotactic body radiotherapy to extend the clinical benefit of PD-1 inhibitors in recurrent/metastatic nasopharyngeal carcinoma.
    Chen, Yu
    Guo, Qiaojuan
    Lin, Jin
    Chen, Gang
    Pan, Leong Kin
    Wang, Yuqi
    Lin, Shaojun
    Chen, Mei
    Chen, Chuanben
    Zhang, Lurong
    Ye, Yunbin
    Lu, Jian-ping
    Zong, Jingfeng
    Lu, Tian Zhu
    Tang, Lina
    Zhang, Li
    Lin, Ya
    Guo, Fang
    Guo, Zeng-qing
    Pan, Jian-ji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion
    Mathew, Ashwathy Susan
    Atenafu, Eshetu G.
    Owen, Dawn
    Maurino, Chris
    Brade, Anthony
    Brierley, James
    Dinniwell, Robert
    Kim, John
    Cho, Charles
    Ringash, Jolie
    Wong, Rebecca
    Cuneo, Kyle
    Feng, Mary
    Lawrence, Theodore S.
    Dawson, Laura A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 134 : 41 - 51
  • [6] Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory
    Xiang, Yan-Jun
    Wang, Kang
    Zheng, Yi-Tao
    Feng, Shuang
    Yu, Hong-Ming
    Li, Xiao-Wei
    Cheng, Xi
    Cheng, Yu-Qiang
    Feng, Jin-Kai
    Zhou, Li-Ping
    Meng, Yan
    Zhai, Jian
    Shan, Yun-Feng
    Cheng, Shu-Qun
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Long-term Outcomes of Definitive Radiation Therapy for Nasopharyngeal Carcinoma at a North American Institution
    Setton, J.
    Tam, M.
    Lian, M.
    Torres, M.
    Wolden, S. L.
    Rao, S. S.
    Lee, N. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S81 - S81
  • [8] Long-term Outcomes of Intensity Modulated Radiation Therapy for T1-T2 Nasopharyngeal Carcinoma
    Wu, M.
    He, X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E318 - E318
  • [9] Long-term Outcomes of Stereotactic Body Radiation Therapy for Organ-confined Prostate Cancer
    Meier, R.
    Cotrutz, C.
    Loiselle, C.
    Sima, S.
    Vermeulen, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S417 - S417
  • [10] Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation
    O'Connor, John K.
    Trotter, James
    Davis, Gary L.
    Dempster, Jane
    Klintmalm, Goran B.
    Goldstein, Robert M.
    [J]. LIVER TRANSPLANTATION, 2012, 18 (08) : 949 - 954